Tradestie Institutional Equity Comparison Engine

DSGN vs SVRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SVRA Overall Edge

SVRA Captures Institutional Edge (2โ€“2 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Savara Inc. (SVRA) driven by superior Valuation, Options & Structure while DSGN counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, DSGN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SVRA at 0.4x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against SVRA sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SVRA
DSGN N/M vs SVRA 0.4x Fwd P/E
Growth & Margin Winner DSGN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner DSGN
1Y +40.8% vs +3.9% ยท 52W Pos 30% vs 13%
Options & Structure Winner SVRA
BREAKDOWN (13th %ile IV) vs BREAKDOWN (17th %ile IV)
DSGN NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap $677.5M
1M Return -3.59%
1Y Return +40.79%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 63.0 Mom 54.0
SVRA NASDAQ
Savara Inc.
Pharmaceutical Preparations
$4.42
-4.63% 1D
Market Cap $1.1B
1M Return -0.56%
1Y Return +3.87%
Forward P/E 0.4x
Unified AI Score
57.7 / 100 HOLD
Tech 42.0 Fund 54.0 Flow 70.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DSGN +40.79% SVRA +3.87% Spread: +36.92 pp (DSGN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DSGN Revenue SVRA Revenue DSGN Op. Margin SVRA Op. Margin Margin Edge
FY2010 N/A $0M N/A -1746.5% SVRA
FY2015 N/A $0M N/A -10968.5% SVRA
FY2016 N/A $0M N/A -2737.0% SVRA
FY2020 $0M $0M -3685.8% -19182.9% DSGN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DSGN (3) vs SVRA (4)
Institutional Metric DSGN SVRA Criterion Row Winner
Market Capitalization Scale $677.5M $1.1B Larger Scale SVRA
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple SVRA
Forward P/E Ratio Valuation N/M 0.4x Lower Multiple SVRA
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -36.9% -151.0% Higher ROE DSGN
52-Week Range Position Momentum 30% ($7โ€“$17) 13% ($4โ€“$7) Stronger Trend DSGN
Beta / 30D Volatility Risk Regime 1.32ฮฒ ยท 61% Vol 1.48ฮฒ ยท 73% Vol Lower Realized Risk DSGN
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 57.7 / 100 (HOLD) Higher Composite SVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DSGN vs SVRA Buy Guide
DSGN BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DSGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SVRA BREAKDOWN
92d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DSGN nor SVRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.